Pfizer hasn’t delivered conclusive proof to back up its confidence on the value of booster shots in fighting COVID variants.
Sarah Jane Tribble | Kaiser Health News
HHS plan to improve rural health focuses on better broadband, telehealth services
Rural health care has increasingly become a focus for the Trump administration as COVID-19 kills hundreds of Americans every day.
Trump’s budget swings at drug prices with a glancing blow
President Donald Trump’s new budget proposal flirts with combating high prescription drug prices, but industry watchers say the tweaks to Medicare and Medicaid do little more than dance around the edges of lowering the actual prices of drugs.
Pressure builds to cut Medicare patients in on prescription deals
Medicare enrollees, who have watched their out-of-pocket spending on prescription drugs climb in recent years, might be in for a break. Federal officials are exploring how beneficiaries could get a share of certain behind-the-scenes fees and discounts negotiated by insurers and pharmacy benefit managers, or PBMs, who together administer Medicare’s Part D drug program.